Axa’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,000
Closed -$301K 1080
2023
Q1
$301K Buy
+16,000
New +$301K ﹤0.01% 1021
2021
Q2
Sell
-75,017
Closed -$1.94M 1248
2021
Q1
$1.94M Sell
75,017
-19,596
-21% -$505K 0.01% 854
2020
Q4
$5.06M Sell
94,613
-61,612
-39% -$3.29M 0.02% 690
2020
Q3
$6.45M Buy
156,225
+38,904
+33% +$1.6M 0.02% 563
2020
Q2
$5.69M Buy
117,321
+35,400
+43% +$1.72M 0.02% 580
2020
Q1
$3.46M Sell
81,921
-68,383
-45% -$2.89M 0.02% 615
2019
Q4
$6.43M Buy
150,304
+70,104
+87% +$3M 0.03% 557
2019
Q3
$2.89M Buy
+80,200
New +$2.89M 0.01% 791
2017
Q3
Sell
-61,875
Closed -$1.73M 1307
2017
Q2
$1.73M Sell
61,875
-102,639
-62% -$2.86M 0.01% 812
2017
Q1
$5.66M Sell
164,514
-5,061
-3% -$174K 0.03% 574
2016
Q4
$4.89M Buy
169,575
+3,236
+2% +$93.3K 0.02% 587
2016
Q3
$5.29M Buy
166,339
+95
+0.1% +$3.02K 0.02% 559
2016
Q2
$5.4M Sell
166,244
-149,938
-47% -$4.87M 0.02% 550
2016
Q1
$8.84M Sell
316,182
-5,108
-2% -$143K 0.04% 418
2015
Q4
$11.5M Sell
321,290
-6,753
-2% -$241K 0.05% 353
2015
Q3
$10.8M Buy
328,043
+163,315
+99% +$5.4M 0.04% 360
2015
Q2
$6.9M Hold
164,728
0.03% 503
2015
Q1
$5.37M Buy
164,728
+119,277
+262% +$3.89M 0.02% 577
2014
Q4
$1.44M Buy
45,451
+2,908
+7% +$92.3K 0.01% 877
2014
Q3
$1.05M Sell
42,543
-273
-0.6% -$6.76K ﹤0.01% 896
2014
Q2
$967K Sell
42,816
-1,722
-4% -$38.9K ﹤0.01% 936
2014
Q1
$1.08M Buy
44,538
+2,319
+5% +$56.4K ﹤0.01% 905
2013
Q4
$1.06M Buy
+42,219
New +$1.06M ﹤0.01% 912